Synthesis, Characterization, and Cytotoxicity Evaluation of Methotrexate-Polyethylene Glycol-Glutamic Acid Nanoconjugate as Targeted Drug Delivery System in Cancer Treatment
Authors
Abstract
Introduction: Methotrexate (MTX) is used as a folic acid antagonist in the treatment of many human cancers. Attachment of hydrophilic ligands to MTX improves its efficacy due to reducing toxicity and enzymatic degradation and it also increases its in-vivo half-life.
Materials and Methods: In the present study, pH-responsive nanoconjugates of methoxy poly(ethylene glycol)-glutamic acid methotrexate (mPEG-Glu-MTX) have been prepared and characterized using hydrogen nuclear magnetic resonance (1H-NMR) and Fourier transform infrared (FT-IR). Glutamic acid is attached to the mPEG chain by the carboxylic group and to the MTX via an amide bond to the amine group.
Results: The prepared nanoconjugate has the mean diameter ranging from 160 to 190 nm and, the drug release was significantly
induced two times at the pH of 5.5 and 3.5 compared with pH 7.4 (P < 0.05). The prepared mPEG-Glu-MTX nanoconjugate showed toxicity similar to AGS, MDA, and MCF7 cell lines compared with the free form of MTX (P > 0.1), which indicates that the conjugation does not effect on the MTX cytotoxicity but is expected to be successful in the targeted delivery of MTX.
Conclusion: The results show that manufactured nanoconjugates can be considered as an efficient drug delivery system in the treatment of cancer; however, further studies are needed on the targeting activity of this nanocarrier in in-vivo conditions.
Highlights
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice
Yousefi G, Shafaati A, Zarghi A, Foroutan SM. Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice. Iran J Pharm Res. 2018;17(Suppl2):e126101. doi: https://doi.org/10.22037/ijpr.2018.2370
The Photothermal Effect of Targeted Methotrexate-Functionalized Multi-Walled Carbon Nanotubes on MCF7 Cells
Karimi A, Erfan M, Mortazavi SA, Ghorbani-Bidkorbeh F, Landi B, et al. The Photothermal Effect of Targeted Methotrexate-Functionalized Multi-Walled Carbon Nanotubes on MCF7 Cells. Iran J Pharm Res. 2019;18(Suppl1):e124458. doi: https://doi.org/10.22037/ijpr.2020.14484.12423
Lomustine Loaded Superparamagnetic Iron Oxide Nanoparticles Conjugated with Folic Acid for Treatment of Glioblastoma Multiforma (GBM)
Jafari S, Tavakoli MB, Zarrabi A. Lomustine Loaded Superparamagnetic Iron Oxide Nanoparticles Conjugated with Folic Acid for Treatment of Glioblastoma Multiforma (GBM). Iran J Pharm Res. 2020;19(2):e124651. doi: https://doi.org/10.22037/ijpr.2020.1101032
Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery
Zakeri-Milani P, Najafi-Hajivar S, Sarfraz M, Nokhodchi A, Mohammadi H, et al. Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery. Iran J Pharm Res. 2021;20(3):e124495. doi: https://doi.org/10.22037/ijpr.2021.114429.14842
Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy
Shokri B, Zarghi A, Shahhoseini S, Mohammadi R, Kobarfard F. Design, Synthesis and Biological Evaluation of Ketoprofen Conjugated To RGD/NGR for Targeted Cancer Therapy. Iran J Pharm Res. 2018;17(4):e124878. doi: https://doi.org/10.22037/ijpr.2018.2317
- Scopus by DOI: 1
Last Update: 6 days ago
- Scopus by Title: 1
Last Update: 6 days ago
- Scopus by Title (Ref): 1
Last Update: 6 days ago
- CrossRef: 0
Last Update: 6 days ago